{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:06:14Z","timestamp":1760267174178},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,3]]},"DOI":"10.1212\/wnl.46.3.822","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:18:45Z","timestamp":1336915125000},"page":"822-824","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma"],"prefix":"10.1212","volume":"46","author":[{"given":"Shawn J.","family":"Bird","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Shy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven S.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Albers JW Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989; 12:435-451.","DOI":"10.1002\/mus.880120602"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Noronha AB Harper JR Ilyas AA Reisfeld RA Quarles RH. Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein of human melanoma cells. J Neurochem 1986; 47:1558-1565.","DOI":"10.1111\/j.1471-4159.1986.tb00795.x"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Tsuchida T Saxton RE Morton DL Irie RF. Gangliosides of human melanoma. Cancer 1989; 63:1166-1174.","DOI":"10.1002\/1097-0142(19890315)63:6<1166::AID-CNCR2820630621>3.0.CO;2-5"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","unstructured":"Fong JW Ledeen RW Kundu SK Brostoff SW. Gangliosides of peripheral nerve myelin. J Neurochem 1976; 26:157-162.","DOI":"10.1111\/j.1471-4159.1976.tb04451.x"},{"key":"e_1_3_1_6_2","unstructured":"Saleh MN Khazaeli MB Wheeler RH et al. Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in meastatic melanoma. Cancer Res 1992; 52:4342-4347."},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","unstructured":"Fuller GN Spies JM Pollard JD McLeod JG. Demyelinating neuropathy triggered by melanoma immunotherapy. Neurology 1994; 44:2404-2405.","DOI":"10.1212\/WNL.44.12.2404"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Shy ME Evans VA Lublin FD et al. Antibodies to GM1 and GD1 in patients with motor neuron disease without plasma cell dyscrasia. Ann Neurol 1989; 25:511-513.","DOI":"10.1002\/ana.410250517"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","unstructured":"Nobile-Orozio E Vierotisz T Messito MJ Sherman WH Latov N. Anti-MAG IgM antibodies in patients with neuropathy and IgM M-proteins: detection by ELISA. Neurology 1983; 33:939-942.","DOI":"10.1212\/WNL.33.7.939"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Creagan ET. Regional and systemic strategies for metastatic malignant melanoma. Mayo Clin Proc 1989; 64:852-860.","DOI":"10.1016\/S0025-6196(12)61759-5"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Bystryn JC Rigel D Friedman RJ Kopf A. Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol 1987; 123:1053-1055.","DOI":"10.1001\/archderm.123.8.1053"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.46.3.822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:06:25Z","timestamp":1711548385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.46.3.822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["10.1212\/WNL.46.3.822"],"URL":"https:\/\/doi.org\/10.1212\/wnl.46.3.822","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}